Humana Inc.
NYSE-HUM
Company Overview
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Name
Humana Inc.
CEO
Mr. James A. Rechtin M.B.A.
Website
www.humana.com
Sector
Health Care Providers and Services
Year Founded
1961
Profile
Market Cap
$39.51B
EV
$47.34B
Shares Out
120.4M
Revenue
$112.04B
Employees
67,600
Margins
Gross
15.48%
EBITDA
3.8%
Operating
3.47%
Pre-Tax
2.11%
Net
1.53%
FCF
-4.51%
Returns (5Yr Avg)
ROA
7.44%
ROTA
21.87%
ROE
20.36%
ROCE
18.15%
ROIC
20.66%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$393.73
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$5,501M
Net Debt
$7,769M
Debt/Equity
0.79
EBIT/Interest
6.63
Growth (CAGR)
Rev 3Yr
11.67%
Rev 5Yr
13.03%
Rev 10Yr
9.69%
Dil EPS 3Yr
-9.55%
Dil EPS 5Yr
-5.23%
Dil EPS 10Yr
7.7%
Rev Fwd 2Yr
4.53%
EBITDA Fwd 2Yr
-9.94%
EPS Fwd 2Yr
-12.29%
EPS LT Growth Est
4.84%
Dividends
Yield
—
Payout
25.21%
DPS
$3.54
DPS Growth 3Yr
10.13%
DPS Growth 5Yr
11.01%
DPS Growth 10Yr
12.5%
DPS Growth Fwd 2Yr
8.18%